aphidicolin-17-monoacetate(51103-57-2)
- Name: aphidicolin-17-monoacetate
- Synonyms:8,11a-Methano-11aH-cyclohepta[a]naphthalene-4,9-dimethanol,tetradecahydro-3,9-dihydroxy-4,11b-dimethyl-, a9-acetate, (3a,4a,4aa,6ab,8b,9b,11ab,11bb)- (9CI); Aphidicolin 17-acetate; Aphidicolin 17-monoacetate
- Molecular Formula:C22H36 O5
- Molecular Weight:380.525
- CAS Registry Number:51103-57-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.51103-57-2 aphidicolin-17-monoacetate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.51103-57-2 aphidicolin-17-monoacetate
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.51103-57-2 aphidicolin-17-monoacetate
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:aphidicolin-17-monoacetate
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]

Other Product
- 58965-86-9/N-(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-N~2~,N~2~-dimethylglycinamide
- 68186-60-7/2,3-dihydroxypropyl decanoate - 2-benzofuran-1,3-dione (1:1)
- 32601-90-4/2-(dibromomethyl)quinoxaline
- 26090-23-3/2-(diethylamino)ethyl 4-[(2-methoxybenzoyl)amino]benzoate
- 20975-63-7/methyl (4-iodo-3-methylphenyl)dithiocarbamate
- 60874-90-0/Naphthalenesulfonic acid, (1-methylethyl)(2-methylpropyl)-, sodium salt
- 23315-33-5/7a,10a-Dihydro-4-(2-hydroxyethyl)-5-methoxy-2H-furo[3',2':4,5]furo[2,3-h]-1-benzopyran-2-one
- 21678-22-8/Cyclodeca[b]furan-6-carboxylic acid,4,7,8,11-tetrahydro-3,10-dimethyl-,methyl ester,(5E,9E)-
- 78513-19-6/[(1R,7aR)-1-(acetyloxy)-2,3,5,7a-tetrahydro-1H-pyrrolizin-7-yl]methyl 2-(acetyloxy)-2-methylbutanoate
- 75057-89-5/4-(dimethylamino)-N-hydroxybenzamide
- 43001-81-6/2-[(7-amino-1-naphthyl)sulphonyl]ethanol
- 87233-61-2/Emedastine
- 82534-75-6/(3R,12aR)-3,6α,9β-Trimethyl-3β,12α-epoxy-3,4,5,5aα,6,7,8,8aα,9,10-decahydro-10α-ethoxypyrano[4,3-j]-1,2-benzodioxepin
- 105734-67-6/1-(5-chloro-1,2-benzothiazol-3-yl)-3-(4-methoxyphenyl)urea
- 69226-59-1/N-(2,4-Dimethoxyphenethyl)-N-methylurea
- 14457-55-7/Epsomite (Mg(SO4).7H2O)(9CI)
- 156532-80-8/Neurexin ibeta
- 89728-83-6/4,8-Epoxyazulene-1,5-diol,decahydro-1,4- dimethyl-7-(1-methylethyl)-,(1R,3aS,4S,5R,- 7R,8S,8aS)-rel-(+)-
- 34244-14-9/1-CHLOROPYRENE
- 51103-57-2/aphidicolin-17-monoacetate
- 15590-23-5/Methane, sulfinylbis-,ion(1-), sodium (9CI)
- 6754-91-2/2-methoxy-N-(methylcarbamoyl)benzamide
- 137791-98-1/t-Hexyl peroxy-2-ethyl hexanoate
- 168146-18-7/â-D-Glucopyranoside,(3â,4R,16â,20â)-16,23,28,- 29-tetrahydroxyoleana-11,13(18)-dien-3-yl O-6-deoxy-R-L-mannopyranosyl-(1f4)-O- [â-D-glucopyranosyl-(1f6)]-
- 185202-53-3/Ligulaverin A
- 54226-87-8/Alectoronic acid
- 14041-22-6/difluoro(oxo)silane
- 110064-60-3/1-Benzopyrylium,3-[[6-O-[2,5-bis-O-[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-a-L-arabinofuranosyl]-b-D-glucopyranosyl]oxy]-7-[[6-O-[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-b-D-glucopyranosyl]oxy]-2-[3-[[6-O-[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propenyl]-b-D-glucopyranosyl]oxy]-4-hydroxyphenyl]-5-hydroxy-,chloride (9CI)
- 87553-68-2/1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, salt with 5-[[3,3'-dichloro-4'-[(2- hydroxy-1-naphthalenyl)azo][1,1'-biphenyl]-4-yl]azo ]-6-hydroxy-2-naphthalenesulfonic acid (1:1)
- 3975-08-4/1,1,4,4-TETRAETHOXY-2-BUTYNE,99%